EU Secures Additional 200 Million Doses of Coronavirus Vaccine

Amid concern US President Donald Trump will pressure regulators to approve a vaccine ahead of the presidential election in November, the CEOs of nine companies — including BioNTech and Pfizer — this week pledged to "uphold the integrity of the scientific process".

Read also: Western Coronavirus Vaccine Producers Pledge to Uphold Testing Rigor

Specifically, the companies said they would only seek emergency authorizations for vaccines "after demonstrating safety and efficacy through a Phase 3 clinical study that is designed and conducted to meet requirements of expert regulatory authorities such as FDA", the US Food and Drug Administration. 

(Writer & Editor: DC-HMN/MFP/WAI, Agence France-Presse)

Source: http://u.afp.com/3ETa